95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
61.12%
Revenue growth above 1.5x FSM's 32.54%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
80.95%
Positive gross profit growth while FSM is negative. John Neff would see a clear operational edge over the competitor.
49.00%
EBIT growth below 50% of FSM's 125.95%. Michael Burry would suspect deeper competitive or cost structure issues.
49.00%
Operating income growth under 50% of FSM's 125.95%. Michael Burry would be concerned about deeper cost or sales issues.
77.62%
Net income growth under 50% of FSM's 266.01%. Michael Burry would suspect the firm is falling well behind a key competitor.
157.14%
EPS growth at 50-75% of FSM's 266.09%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
157.14%
Diluted EPS growth at 50-75% of FSM's 266.09%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
2.51%
Share change of 2.51% while FSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
2.79%
Diluted share change of 2.79% while FSM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
76.90%
OCF growth above 1.5x FSM's 9.89%. David Dodd would confirm a clear edge in underlying cash generation.
56.72%
FCF growth above 1.5x FSM's 6.29%. David Dodd would verify if the firm’s strategic investments yield superior returns.
111913529.36%
10Y CAGR of 111913529.36% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
347.36%
5Y revenue/share CAGR under 50% of FSM's 32541.23%. Michael Burry would suspect a significant competitive gap or product weakness.
88.39%
3Y revenue/share CAGR similar to FSM's 92.85%. Walter Schloss would assume both companies experience comparable short-term cycles.
56378.70%
10Y OCF/share CAGR above 1.5x FSM's 1799.79%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
751.37%
5Y OCF/share CAGR above 1.5x FSM's 294.78%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
129.26%
Positive 3Y OCF/share CAGR while FSM is negative. John Neff might see a big short-term edge in operational efficiency.
1226663.69%
Net income/share CAGR above 1.5x FSM's 728.93% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
816.94%
5Y net income/share CAGR above 1.5x FSM's 272.60%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
212.66%
3Y net income/share CAGR above 1.5x FSM's 94.20%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
347.46%
5Y equity/share CAGR 1.25-1.5x FSM's 235.05%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
82.95%
3Y equity/share CAGR above 1.5x FSM's 31.37%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.10%
Firm’s AR is declining while FSM shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
11.48%
Asset growth well under 50% of FSM's 30.00%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
11.57%
Under 50% of FSM's 33.30%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.25%
We’re deleveraging while FSM stands at 11.41%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
29.55%
We expand SG&A while FSM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.